• Fingolimod (FTY720): A Trafficking-to-Assay Guide

  2026-08-13

  Fingolimod (FTY720) is more than an oral multiple sclerosis therapy: it is a powerful tool for dissecting S1P-controlled immune-cell trafficking, CNS signaling, and assay interpretation. This guide connects its mechanism with lessons from magnetic CAR-T-mimicking cell research while clearly separating established evidence from experimental opportunities.

• Fluo-4 AM Calcium Assay Kit for Mechanotransduction

  2026-08-12

  Use the Fluo-4 AM Calcium Assay Kit to connect scaffold mechanics with live intracellular calcium detection in annulus fibrosus cells. Its 488 nm-compatible, no-wash workflow also supports scalable GPCR inhibitor screening and GPCR agonist screening when kinetic signal quality and cell viability matter.

• Pexmetinib (ARRY-614): A State-Aware Assay Guide

  2026-08-12

  Pexmetinib (ARRY-614) is a dual kinase probe for connecting cytokine output with p38 MAPK and Tie2 pathway behavior. This guide explains how recent structural findings on p38α dephosphorylation can improve assay design, interpretation, and translational relevance.

• Annexin V-Cy5 Apoptosis Kit for Microglia

  2026-08-11

  Use rapid phosphatidylserine labeling to separate genuine cell death from lysosomal stress in microglia and other experimental systems. The Annexin V-Cy5 Apoptosis Kit supports complementary flow cytometry and fluorescence microscopy workflows, helping researchers validate whether a treatment changes apoptosis, clearance, or intracellular digestion.

• Annexin V-Cy5 Apoptosis Kit for Microglia

  2026-08-11

  The Annexin V-Cy5 Apoptosis Kit provides a rapid way to separate phosphatidylserine exposure from lysosomal stress in microglial models. This article translates a reversible zebrafish microglia study into practical microscopy and flow cytometry apoptosis detection workflows, with optimization guidance for difficult samples.

• Platanoside, Ferroptosis, and Acute Lung Injury

  2026-08-10

  The reference study identifies an autophagy-dependent Keap1 degradation mechanism through which platanoside activates the Nrf2/GPX4 antioxidant axis and suppresses ferroptosis in lipopolysaccharide-induced acute lung injury. Its findings connect Keap1–p62 complex formation with reduced lipid peroxidation, mitochondrial damage, inflammation, and histological injury, while also highlighting the need for broader causal validation.

• Annexin V-Cy5 Apoptosis Kit Workflow

  2026-08-09

  Build a rapid Annexin V apoptosis detection workflow for distinguishing apoptotic signaling from lysosomal stress, with microscopy and flow cytometry options. The Annexin V-Cy5 Apoptosis Kit provides a practical complement to microglial imaging, phagocytosis, and transcriptomic assays in reversible neuroimmune-stress models.

• ARCA EGFP mRNA for Reliable Cell Assays

  2026-08-08

  Learn how ARCA EGFP mRNA (SKU R1001) functions as a direct fluorescence reporter for separating transfection performance from cell viability and cytotoxicity results. This scenario-based guide covers reporter selection, handling, optimization, and interpretation in mammalian cell workflows.

• CTP Solution for Reliable mRNA Synthesis

  2026-08-07

  CTP Solution (100 mM) provides a defined, nuclease-free nucleotide input for in vitro transcription workflows that support engineered mRNA and lipid nanoparticle studies. This article connects upstream Cytidine-5'-triphosphate control with the localized p21 mRNA–LNP strategy reported for bladder cancer, while separating documented findings from practical pilot recommendations.

• Protease Inhibitor Cocktail (EDTA-Free): Precision for OXPHO

  2026-08-07

  Explore how the Protease Inhibitor Cocktail (EDTA-Free) uniquely supports high-fidelity OXPHOS assays and advanced protein stability work. This article offers a deep, scientific perspective on protease inhibition in mitochondrial research, bridging mechanistic insight and cutting-edge practical applications.

• Novel PDK4 Inhibitors: Allosteric Modulation for Metabolic D

  2026-08-06

  Jeon et al. identified a new class of potent, allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with lead compound 8c showing high in vitro potency, metabolic stability, and efficacy in preclinical models of metabolic, allergic, and oncologic disease. These findings establish a validated scaffold for future drug development targeting PDK4-driven metabolic dysregulation.

• Lycorine Induces Apoptosis in Pancreatic Cancer via ALDH3A1

  2026-08-06

  This study elucidates how lycorine, a natural alkaloid, inhibits pancreatic cancer cell proliferation and induces apoptosis by targeting ALDH3A1 and disrupting fatty acid oxidation. The integration of transcriptomics and molecular docking provides novel mechanistic insight, with implications for developing targeted therapeutics addressing metabolic vulnerabilities in pancreatic cancer.

• UBE2F-SAG Mediated RHEB Neddylation Drives mTORC1 in Liver C

  2026-08-05

  This study uncovers RHEB as a direct neddylation substrate of the UBE2F-SAG axis, elucidating a novel regulatory mechanism that enhances mTORC1 activity in hepatocellular carcinoma. These findings offer mechanistic insight into liver tumorigenesis and suggest new therapeutic entry points targeting the neddylation pathway.

• IPR-803: Urokinase Receptor Inhibitor for Tumor Invasion Con

  2026-08-05

  IPR-803 stands out as a selective urokinase receptor inhibitor that reliably blocks tumor invasion and metastasis, with validated efficacy in both breast and pancreatic cancer models. Its unique mechanistic action and robust performance make it a cornerstone for advanced cancer research workflows.

• Puromycin Aminonucleoside: Optimizing Podocyte Injury Models

  2026-08-04

  Puromycin aminonucleoside remains the gold standard for inducing podocyte injury and modeling nephrotic syndrome, enabling precise glomerular lesion induction and proteinuria. Recent workflow advances and solubilization strategies—drawn from cutting-edge proteomic research—are enhancing assay reproducibility and sensitivity, positioning APExBIO’s reagent at the forefront of renal pathobiology research.

8010 records 3/534 page Previous Next 12345 下5页 Last page